Citadel Advisors’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

Citadel Advisors’s Portfolio SHACW Stock Details SHACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-139,893	Closed	-$4K	–	15896
2022 Q3	$4K	Sell	139,893 -24,402	-15%	-$1.22K	﹤0.01%	12403
2022 Q2	$13K	Sell	164,295 -271,738	-62%	-$37.9K	﹤0.01%	12536
2022 Q1	$88K	Sell	436,033 -83,426	-16%	-$32.2K	﹤0.01%	12405
2021 Q4	$286K	Sell	519,459 -94,713	-15%	-$55.7K	﹤0.01%	11035
2021 Q3	$356K	Buy	614,172 +255,399	+71%	+$180K	﹤0.01%	10685
2021 Q2	$305K	Buy	358,773 +184	+0.1%	+$118	﹤0.01%	11225
2021 Q1	$212K	Buy	+358,589	New	+$220K	﹤0.01%	11583

Citadel Advisors's SHACW Position: Q4 2022 in Review

Citadel Advisors sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q4 2022, closing a stake of 139,893 shares — an estimated $4K sold.

Citadel Advisors first reported a position in SHACW in Q1 2021 and held it in 7 quarters. The position peaked at $356K in Q3 2021. 0 funds tracked by Wall St. Rank hold SHACW as of Q4 2022.

Citadel Advisors reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q4 2022 after selling out during the quarter.
Citadel Advisors sold 139,893 SCP & CO Healthcare Acquisition Company Warrant shares in Q4 2022, an estimated $4K.
Citadel Advisors first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q1 2021 and held it in 7 quarters.
Citadel Advisors's SCP & CO Healthcare Acquisition Company Warrant position peaked at $356K in Q3 2021.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.